N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide

N2‑({[(4‑Bromophenyl)Methyl]Oxy}Carbonyl)‑N1‑[(1s)‑1-Formylpentyl]‑L-Leucinamide is a synthetic small molecule and a derivative of the amino acid leucine. It features a carbamate linkage to a 4-bromobenzene moiety and an amide bond to an N-formypentanyl group. The compound is classified as an amino acid, peptide, and analogue, specifically within the carboxylic acids and derivatives class. There are no approved medical indications or clinical trials for this molecule; it is considered experimental with no known therapeutic use or mechanism of action established in humans[2][3][5]. Its structure has been studied in protein-ligand complexes but there is no evidence of pharmaceutical development or commercial manufacturing.

Other names

(4-bromophenyl)methyl N-[(1S)-3-methyl-1-{[(2S)-1-oxohexan-2-yl]carbamoyl}butyl]carbamate(4-bromophenyl)methyl N-((1S)-3-methyl-1-(((2S)-1-oxohexan-2-yl)carbamoyl)butyl)carbamate